Current Opinion in Allergy and Clinical Immunology was launched in 2001. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The fields of allergy and clinical immunology are divided into 13 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Journal's Section Editors for this issue.
Susan M. Tarlo
Dr Susan M. Tarlo MB BS FRCP(C) is a Professor in the Department of Medicine and in the Dalla Lana School of Public Health at the University of Toronto, Canada. She is a respiratory physician at the University Health Network, Toronto Western Hospital and at the Gage Occupational and Environmental Health Unit and Centre of Research Excellence in Occupational Diseases of St Michael's Hospital in Toronto, Canada. Her main areas of clinical practice and research are in occupational and environmental lung diseases and allergic responses, especially occupational asthma. She initially graduated from medical school at London University, England, and underwent postgraduate training in England for four years before coming to Queen's University, Kingston, Ontario, Canada for a year as a fellow in Allergy and Clinical Immunology, followed by Respiratory Medicine residency for two years at McMaster University, Hamilton, Canada. She has been in Toronto as a staff physician at the Toronto General Hospital and then at Toronto Western Hospital as well as at the Gage Occupational and Environmental Health Unit since 1976 as well as holding academic positions at the University of Toronto since that time.
Dr Maestrelli, M.D., completed his medical degree at University of Padova, Italy, and then specialised in occupational medicine and in pulmonology. He completed a two year post doctoral fellowship at the Institute of Occupational Medicine, University of Padova, and then a two year research fellowship at the Department of Allergy and Clinical Immunology of Cardiothoracic Institute, London, U.K.
Dr Maestrelli has written over 100 scientific papers and book chapters, and has lectured nationally and internationally. He has been Chairman of the Interest Group on Occupational Allergy of European Academy of Allergology and Clinical Immunology for three years.
He is currently Professor of occupational medicine at University of Padova, Italy, and Director of the Laboratory of Lung Pathophysioly of the Department of Environmental Medicine and Public Health at the University Hospital of Padova.
Carlos E. Baena-Cagnani
Professor Carlos E. Baena-Cagnani, a specialist in allergology, immunology and respiratory medicine, is former President of the World Allergy Organisation (WAO). He is a Professor in the Postgraduate Department of the Faculty of Medicine at the Catholic University, Cordoba, Argentina and the Specialty School in pediatric Respiratory and Allergy, University of Genoa, Italy.
He is former President of the Latin American Society of Allergy and Immunology and the Argentinean Association of Allergy and Clinical Immunology. He is a member of the Global Initiative for Asthma (GINA) Assembly, and currently Prof. Baena-Cagnani is a member of the Executive Committee and Latin America Chairman for the Allergic Rhinitis Impact on Asthma-the World Health Organization (ARIA–WHO) committee. He is member of the Executive Committee of the Global Alliance against chronic Respiratory Diseases (GARD) of WHO.
He trained in allergy and respiratory medicine at the University Clinic of the University of Navarra, Pamplona, Spain, and completed his speciality and training in clinical research at the South Florida University in Tampa, USA. His main research interests focus on the epidemiology of asthma and allergy, with a particular emphasis on risk factors including allergen exposure. Professor Baena-Cagnani is also involved in clinical trials for the treatment of asthma and rhinitis and its co-morbidities, and sublingual immunotherapy in children. He has presented at more than 250 meetings and seminars throughout the world on such topics as asthma, rhinitis, immunotherapy and has led educational asthma plans in different Latin American countries. Additionally, he has coordinated the phase III International Study of Asthma and Allergies in Childhood (ISAAC) in Argentina. Professor Baena-Cagnani is a member of the editorial board and contributing Editor of several international scientific journals, and has published numerous manuscripts in peer-reviewed journals.
Dr Bacharier is an Associate Professor of Pediatrics at Washington University School of Medicine, USA and Clinical Director of the Division of Pediatric Allergy, Immunology and Pulmonary Medicine. He received his undergraduate degree in biophysics from The Johns Hopkins University, USA and his medical degree from Washington University School of Medicine. Dr Bacharier was an intern and resident in pediatrics at St. Louis Children's Hospital and a fellow in Pediatric Allergy and Immunology at Children's Hospital, Boston and Harvard Medical School, Boston USA. He was a recipient of the 2005 Samuel R. Goldstein Leadership Award in Medical Student Education from Washington University School of Medicine and is a member of several organizations including the American Academy of Allergy, Asthma and Immunology and the American Thoracic Society. Dr Bacharier's research focuses on childhood asthma. Specifically, he is an investigator in the Childhood Asthma Management Program (CAMP), a multi-centered prospective trial examining the effects of early treatment of asthma on lung growth. He is a Principal Investigator in the NHLBI-funded AsthmaNet and an Investigator in the Childhood Asthma Research and Education (CARE) Network: 2 multi-centered networks examining therapeutic approaches to childhood asthma. He is also an Investigator in the American Lung Association's Asthma Clinical Research Center Network. Dr Bacharier is also currently investigating the role of early infection with Respiratory Syncytial Virus upon the subsequent development of asthma. These research projects have been published in numerous journals, including the New England Journal of Medicine, The Journal of Allergy and Clinical Immunology, Pediatrics, and The American Journal of Respiratory and Critical Care Medicine. Dr Bacharier serves on the Reviewer Board of The Journal of Allergy and Clinical Immunology and has been a guest editor for Immunology and Allergy Clinics of North America.